Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 12;6(1):4.
doi: 10.1186/1939-4551-6-4.

Recognition of allergic conjunctivitis in patients with allergic rhinitis

Daniel C Williams  1 , Gabrielle Edney, Bianca Maiden, Peter K Smith
Affiliations

Recognition of allergic conjunctivitis in patients with allergic rhinitis

Daniel C Williams et al. World Allergy Organ J. .

Abstract

Aims: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis.

Methods: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify "silent" disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms.

Results: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine.

Conclusions: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC.

PubMed Disclaimer

References

    1. DeWester J, Philpot EE, Westlund RE. et al.The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;6:331–337. Abstract. - PubMed
    1. Meltzer EO, Bachert C, Bloom M. et al.Efficacy of intranasal mometasone furoate for the treatment of ocular symptoms in patients with seasonal allergic rhinitis. Allergy Clin Immunol Int. 2005;6:Abstract 709.
    1. Neffen H, Mello JF, Sole D, Naspitz CK, Dodero AE, Garza HL. et al.Nasal allergies in the Latin American population: results from the allergies in Latin America survey. Allergy Asthma Proc. 2010;6(Supp1):S9–S27. - PubMed
    1. Austin JB, Kaur B, Anderson HR. et al.Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood) Arch Dis Child. 1999;6:225–230. doi: 10.1136/adc.81.3.225. Abstract. - DOI - PMC - PubMed
    1. Nathan RA, Meltzer EO, Selner JC. et al.Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;6:S808–S814. doi: 10.1016/S0091-6749(97)80040-1. - DOI - PubMed